As a pediatric psychiatric nurse practitioner, I hear the same frustrating story from parents almost every week: “My child has been on ADHD medication for months, but they are still struggling at home and falling behind in the classroom.”
When a child is taking medication but not seeing relief, parents understandably feel defeated. They wonder if they chose the wrong medication, or if they are doing something wrong.
But usually, the medication is not the problem. The process is the problem.
Standard, insurance-driven clinic models often trap kids in what we call “treatment as usual”, or routine community care. And the hard clinical data shows that this routine care is failing our kids.
The proof: the landmark MTA study
The National Institute of Mental Health funded one of the largest studies ever done on pediatric ADHD, known as the Multimodal Treatment Study (MTA). Researchers wanted to know what happens when you compare children receiving intensive, carefully monitored medication management against children receiving standard community care — the typical insurance-based clinic model.
The results were eye-opening. For over two decades, the data has clearly shown that carefully monitored children achieve vastly superior results in the classroom and at home.
The most striking part: 67% of the children in the community care group were actually taking stimulant medication. The difference in their outcomes was not about whether they took medication. It was about how that medication was managed.
Here is why standard treatment as usual fails so many children with ADHD, and what I do differently.
1. The waiting game
In a standard community care model, a clinic might start your child on a medication and then tell you to come back in three to six months for a rushed, ten-minute medication check.
The MTA study found that the children who did well had monthly, thirty-minute visits with their provider. ADHD needs close monitoring. A child should not have to struggle through an entire grading period before anyone has time to check in and adjust the plan.
2. Lingering on low doses
Finding the right ADHD medication is only half the work. Finding the right dose — titration — is the other half. In the MTA study, children in routine community care were routinely left on doses roughly 10 to 15 mg/day lower than what they actually needed.
Because standard clinics do not have the time to see patients frequently, providers are often left prescribing a low, sub-therapeutic dose and leaving the child there. The child takes on all the hassle of a daily medication and rarely reaches the dose that would actually help them focus.
3. Missing the teacher’s voice
A child’s ADHD symptoms often look very different at the kitchen table than they do during third-period math. In the intensive MTA model, medication was adjusted using structured, regular feedback from both parents and teachers. In standard community care, that feedback loop almost never exists.
What I do differently
The central lesson of the MTA study is straightforward: ADHD requires ongoing, high-quality, closely monitored care. Titration — adjusting doses safely, talking to the school, checking in often — is what moves the needle.
This is exactly why I built Kindred Family Care in Mayfield Heights as a direct-pay practice.
Without insurance company red tape, I am not forced into the treatment-as-usual box. I have the time and flexibility to follow the evidence-based standard. I work closely with your family, I talk to your child’s school psychologists, and I see you frequently until we find the most conservative medication strategy that actually works.
Your child does not have to spend another school year on a treatment plan that is not working.
If you are in the Greater Cleveland or Northeast Ohio area, you can book a free 25-minute consultation using the link at the top of this page.
Reference: Jensen, P. S., et al. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Archives of General Psychiatry, 56(12), 1073–1086. https://doi.org/10.1001/archpsyc.56.12.1073